APALUTAMIDE FOR METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER IN TITAN: PROGNOSTIC IMPORTANCE OF PROSTATE-SPECIFIC ANTIGEN RESPONSES

被引:0
|
作者
Chowdhury, Simon
Bjartell, Anders
Agarwal, Neeraj
Chung, Byung Ha
Given, Robert W.
Pereira de Santana Gomes, Andrea J.
Merseburger, Axel S.
Ozguroglu, Mustafa
Juarez Soto, Alvaro
Uemura, Hirotsugu
Ye, Dingwei
Lopez-Gitlitz, Angela
Londhe, Anil
Mundle, Suneel
Larsen, Julie S.
McCarthy, Sharon
Chi, Kim N.
机构
来源
JOURNAL OF UROLOGY | 2020年 / 203卷
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
PD10-11
引用
收藏
页码:E250 / E250
页数:1
相关论文
共 50 条
  • [41] Apalutamide (APA) plus androgen deprivation therapy (ADT) for metastatic castration-sensitive prostate cancer (mCSPC): Analysis of pain and fatigue in the TITAN study
    Chung, B. H.
    McQuarrie, K.
    Bjartell, A.
    Chowdhury, S.
    Pereira de Santana Gomes, A. J.
    Ozguroglu, M.
    Juarez Soto, A.
    Merseburger, A. S.
    Uemura, H.
    Ye, D.
    Given, R.
    Miladinovic, B.
    Li, N.
    Hudgens, S.
    Floden, L.
    Lopez-Gitlitz, A.
    Chi, K. N.
    Agarwal, N.
    ANNALS OF ONCOLOGY, 2019, 30
  • [42] Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study
    Chi, Kim N.
    Chowdhury, Simon
    Bjartell, Anders
    Byung Ha Chung
    Gomes, Andrea J. Pereira de Santana
    Given, Robert
    Juarez, Alvaro
    Merseburger, Axel S.
    Ozguroglu, Mustafa
    Uemura, Hirotsugu
    Ye, Dingwei
    Brookman-May, Sabine
    Mundle, Suneel D.
    McCarthy, Sharon A.
    Larsen, Julie S.
    Sun, Weili
    Bevans, Katherine B.
    Zhang, Ke
    Bandyopadhyay, Nibedita
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (20) : 2294 - +
  • [43] Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN Study REPLY
    不详
    JOURNAL OF UROLOGY, 2021, 206 (04): : 923 - 923
  • [44] Apalutamide (APA) for metastatic castration-sensitive prostate cancer (mCSPC) in TITAN: Outcomes in patients (pts) with low- and high-risk disease
    Ozguroglu, Mustafa
    Chowdhury, Simon
    Bjartell, Anders
    Uemura, Hirotsugu
    Chung, Byung Ha
    Agarwal, Neeraj
    Merseburger, Axel Stuart
    Soto, Alvaro Juarez
    Lopez-Gitlitz, Angela
    Bhaumik, Amitabha
    Larsen, Julie S.
    McCarthy, Sharon Anne
    Chi, Kim N.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [45] Efficacy and safety exposure–response relationships of apalutamide in patients with metastatic castration-sensitive prostate cancer: results from the phase 3 TITAN study
    Huybrecht T’jollyn
    Oliver Ackaert
    Caly Chien
    Angela Lopez-Gitlitz
    Sharon McCarthy
    Carlos Perez Ruixo
    Lawrence Karsh
    Kim Chi
    Simon Chowdhury
    Juan-Jose Perez Ruixo
    Neeraj Agarwal
    Cancer Chemotherapy and Pharmacology, 2022, 89 : 629 - 641
  • [46] PROSTATE-SPECIFIC ANTIGEN KINETICS IN PATIENTS WITH ADVANCED PROSTATE CANCER TREATED WITH APALUTAMIDE: RESULTS FROM THE TITAN AND SPARTAN STUDIES
    Chi, Kim N.
    Saad, Fred
    Chowdhury, Simon
    Graff, Julie N.
    Agarwal, Neeraj
    Oudard, Stephane
    Raritan, Gang Li
    Lopez-Gitlitz, Angela
    Larsen, Julie S.
    McCarthy, Sharon A.
    Mundle, Suneel D.
    Smith, Matthew R.
    Small, Eric J.
    JOURNAL OF UROLOGY, 2021, 206 : E587 - E587
  • [47] Prostate-specific antigen doubling time in metastatic castration-resistant prostate cancer: a clinically useful prognostic factor
    Colloca, G.
    Guarneri, D.
    Addamo, G.
    Venturino, A.
    Coccorullo, Z.
    Ratti, R.
    Campora, E.
    EJC SUPPLEMENTS, 2009, 7 (04): : 14 - 14
  • [48] The prognostic importance of prostate-specific antigen in monitoring patients undergoing maximum androgen blockage for metastatic prostate cancer
    Kiper, Ahmet
    Yigitbasi, Orhan
    Imamoglu, Abdurrahim
    Tuygun, Can
    Turan, Celaleddin
    THESCIENTIFICWORLDJOURNAL, 2005, 5 : 118 - 124
  • [49] How We Treat Metastatic Castration-Sensitive Prostate Cancer
    Ionescu, Filip
    Zhang, Jingsong
    CANCER CONTROL, 2024, 31
  • [50] Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
    Fizazi, Karim
    NamPhuong Tran
    Fein, Luis
    Matsubara, Nobuaki
    Rodriguez-Antolin, Alfredo
    Alekseev, Boris Y.
    Ozguroglu, Mustafa
    Ye, Dingwei
    Feyerabend, Susan
    Protheroe, Andrew
    De Porre, Peter
    Kheoh, Thian
    Park, Youn C.
    Todd, Mary B.
    Chi, Kim N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (04): : 352 - 360